Jennifer E. Graser

Array ( [id] => 8171342 [patent_doc_number] => 20120107363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'IMMUNOGEN AGAINST CAMPYLOBACTER INFECTION' [patent_app_type] => utility [patent_app_number] => 13/343153 [patent_app_country] => US [patent_app_date] => 2012-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2754 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107363.pdf [firstpage_image] =>[orig_patent_app_number] => 13343153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10574421 [patent_doc_number] => 09297049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Strain of Lactobacillus mucosae' [patent_app_type] => utility [patent_app_number] => 14/366745 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4020 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14366745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571223 [patent_doc_number] => 08337864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Modified flagellin improved toll-like receptor 5 stimulating activity' [patent_app_type] => utility [patent_app_number] => 13/333709 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5410 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571224 [patent_doc_number] => 08337865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Modified flagellin improved toll-like receptor 5 stimulating activity' [patent_app_type] => utility [patent_app_number] => 13/333857 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5401 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9581707 [patent_doc_number] => 08771708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Biologically-active radiolabeled Cry1Fa and receptor binding assay methods' [patent_app_type] => utility [patent_app_number] => 13/327842 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8685 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13327842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8663986 [patent_doc_number] => 08377446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Serum resistance factors of gram positive bacteria' [patent_app_type] => utility [patent_app_number] => 13/327882 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 61 [patent_no_of_words] => 29469 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13327882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9093787 [patent_doc_number] => 20130273098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'NOVEL FORMULATIONS WHICH MITIGATE AGITATION-INDUCED AGGREGATION OF IMMUNOGENIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/992844 [patent_app_country] => US [patent_app_date] => 2011-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15164 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9126905 [patent_doc_number] => 08574853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Monoclonal antibodies that neutralize anthrax toxins' [patent_app_type] => utility [patent_app_number] => 13/310463 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 18396 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13310463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254146 [patent_doc_number] => 08617556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Gram-positive bacteria specific binding compounds' [patent_app_type] => utility [patent_app_number] => 13/305659 [patent_app_country] => US [patent_app_date] => 2011-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 29 [patent_no_of_words] => 16440 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13305659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8915972 [patent_doc_number] => 20130177596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'Endophytic Fungi from Pteromischum SP. Plant, Compounds and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/295643 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16049 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158516 [patent_doc_number] => 20120100178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Compositions And Methods For Treatment Of Microbial Infections' [patent_app_type] => utility [patent_app_number] => 13/280049 [patent_app_country] => US [patent_app_date] => 2011-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12996 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100178.pdf [firstpage_image] =>[orig_patent_app_number] => 13280049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9093782 [patent_doc_number] => 20130273093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'Method for Immunising a Subject against Mycobacterium Tuberculosis or Mycobacterium Bovis' [patent_app_type] => utility [patent_app_number] => 13/879983 [patent_app_country] => US [patent_app_date] => 2011-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482897 [patent_doc_number] => 20120282304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'MULTI-COATED LACTIC ACID BACTERIA AND PREPARING METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 13/519540 [patent_app_country] => US [patent_app_date] => 2011-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6418 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171324 [patent_doc_number] => 20120107346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'COMBINATION VACCINES WITH LOW DOES OF HIB CONJUGATE' [patent_app_type] => utility [patent_app_number] => 13/250094 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11798 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107346.pdf [firstpage_image] =>[orig_patent_app_number] => 13250094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238985 [patent_doc_number] => 08603776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Method for preparing xylose-utilizing strain' [patent_app_type] => utility [patent_app_number] => 13/242547 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 3971 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13242547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10876039 [patent_doc_number] => 08900824 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-12-02 [patent_title] => 'High-affinity monoclonal antibodies for botulinum toxin type B' [patent_app_type] => utility [patent_app_number] => 13/243835 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 10741 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13243835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9107155 [patent_doc_number] => 20130280287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'RECOMBINANT MYCOBACTERIUM AS VACCINE FOR USE IN HUMANS' [patent_app_type] => utility [patent_app_number] => 13/822706 [patent_app_country] => US [patent_app_date] => 2011-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6540 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13822706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199860 [patent_doc_number] => 20120123093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'NOVEL SURFACE ANTIGEN' [patent_app_type] => utility [patent_app_number] => 13/232400 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13825 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20120123093.pdf [firstpage_image] =>[orig_patent_app_number] => 13232400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8745545 [patent_doc_number] => 20130085262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'NOVEL SURFACE ANTIGEN' [patent_app_type] => utility [patent_app_number] => 13/232443 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13837 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13232443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10056200 [patent_doc_number] => 09095540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Methods and compositions involving protective staphylococcal antigens' [patent_app_type] => utility [patent_app_number] => 13/821943 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 50142 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821943 [rel_patent_id] =>[rel_patent_doc_number] =>)